Trp53 is arguably the most critical tumour suppressor gene product that inhibits malignant transformation. Besides mutations that inactivate Trp53 functions, genetic polymorphisms have been suggested to be risk factors for cancer. A polymorphic site at codon 72 in exon 4 encodes either an arginine amino acid (Trp53 72R ) or a proline residue (Trp53  72P ) . Previous studies have shown that the Trp53 72R form is more efficient in apoptosis induction, whereas the Trp53 72P form was suggested to induce G1 arrest better. Here we report that Trp53
72P is more efficient than Trp53 72R in specifically activating several Trp53-dependent DNA-repair target genes in several cellular systems. Moreover, using isogenic cell lines and several DNA-repair assays, we show that Trp53 72P cells have a significantly higher DNA-repair capacity than the Trp53 72R cells. Furthermore, Trp53
72P -expressing cells exhibit reduced micronuclei formation compared to Trp53 Introduction
Trp53 is a critical tumour-suppressor gene product that prevents malignant transformation (Vogelstein et al., 2000; Vousden and Lu, 2002; Olivier et al., 2004) . When activated by stress and DNA-damaging signals, cells mediate a Trp53-dependent SOS response that comprises of apoptosis, cell-cycle arrest and DNA-repair (Vogelstein et al. 2000; Vousden and Lu, 2002; Oren, 2003) . The choice of the Trp53-dependent response is thought to depend on the strength of the activating signal and the extent of cellular damage (Vousden and Lu, 2002; Lahav, 2004) . Both transcription-dependent and -independent mechanisms have been suggested to contribute to Trp53-mediated response, although many studies have focused on Trp53's ability to transcriptionally activate target genes as a means of Trp53 function (Vousden and Lu, 2002; Oren, 2003) . Functional inactivation of Trp53 owing to mutations, very often in the DNA-binding domain, results in transcriptionally compromised Trp53 that is not capable of efficiently protecting the damaged cells from genotoxic insults (Vousden and Lu, 2002; Olivier et al., 2004) . In addition to mutations, functional inactivation of Trp53 by binding of viral and other negative regulators have also been suggested to compromise Trp53 function (Vousden and Lu, 2002) . Absence of functionally active Trp53 has been shown to result in spontaneous and induced tumour susceptibility in mice and men (Donehower et al., 1992; Jacks et al., 1994; Evans and Lozano, 1997; Ghebranious and Donehower, 1998) .
Besides the common mechanisms that alter Trp53 function, it has been suggested that genetic polymorphisms in Trp53 could also affect some of its functions. A common polymorphism at codon 72 of Trp53 results in either an arginine residue (Trp53 72R ) or a proline residue (Trp53 72P ) (Harris et al., 1986; Matlashewski et al., 1987; Buchman et al., 1988) . The two polymorphic variants of wild-type Trp53 have been shown to have different biochemical properties such as differential binding to components of the transcriptional machinery, which was suggested to differentially affect their transcriptional abilities (Thomas et al., 1999) . The Trp53 72P form was suggested to activate transcription much more efficiently than the Trp53 72R variant (Thomas et al., 1999) . Moreover, it was also suggested that the Trp53 72R variant is much more susceptible to degradation by the HPV E6 protein (Storey et al., 1998) . Nonetheless, other reports demonstrated that the Trp53 72R variant is more efficient in inducing cell death than the Trp53 72P variant, owing to its greater ability to localize to the mitochondria and induce apoptosis (Dumont et al., 2003; Sullivan et al., 2004) . Recently, the Trp53 72P variant was shown to induce cell-cycle arrest better than the Trp53 72R form (Pim and Banks, 2004) . These data highlight that both the polymorphic variants of Trp53 might have evolved for selectively regulating specific cellular functions.
A role for Trp53 in regulating apoptosis has been clearly established (Schuler and Green, 2001; Haupt et al., 2003) . Activated Trp53 has been shown to induce apoptosis via the activation of targets such as Puma, Noxa, AIP-1 and Bax (Schuler and Green, 2001; Brown and Attardi, 2005) . In addition, there is mounting evidence indicating that Trp53 could activate apoptosis independent of its transcription function, by localizing to the mitochondria (Chipuk and Green, 2003) . Besides apoptosis, there is emerging evidence for Trp53s role in regulating the various DNA-repair processes (Sengupta and Harris, 2005) . Trp53 has been shown to activate DNA-repair target genes such as gadd45 and p48, which regulate the NER, and p53R2, which has been shown to be essential for providing nucleotides during the repair process (Kastan et al., 1992; Hwang et al., 1999; Smith et al., 2000; Tanaka et al., 2000) , among others. Genotoxic insults such as UV irradiation has been shown to lead to the induction of these repair target genes in a Trp53-dependent manner, leading to repair of the damaged DNA. Moreover, defects in proper DNArepair have been suggested to lead to genomic instability, resulting in cancer (Risinger and Groden, 2004; Sengupta and Harris, 2005) .
We have recently shown that healthy Asian heterozygote individuals (Trp53   72R   /Trp53   72P ) tend to preferentially express the Trp53 72P allele at the RNA level . By contrast, the Trp53 72R allele was preferentially expressed in most heterozygote breast cancer patients . These data, together with the many reports indicating that the Trp53 72R was associated with cancer predisposition (Sja¨lander et al., 1996; Weston and Godbold, 1997; Papadakis et al., 2000; Bergamaschi et al., 2003) , suggested to us that although the Trp53 72R form might be capable of inducing apoptosis better, it might not be efficient in preventing cancer formation. We have therefore investigated if the two different Trp53 variants would have differential ability to regulate DNA-repair, a process that is regulated by Trp53 and that is essential for the prevention of accumulation of genomic instability and hence, cancer formation (Risinger and Groden, 2004; Sengupta and Harris, 2005 (Figure 1a ), excluding the possibility that differential expression may account for the observed transactivation differences.
We 72R and Trp53 72P were capable of activating the p21, p53AIP-1 and Mdm2 promoters, which are not directly involved in the DNA-repair process, to similar extends and no significant differences were observed using various concentrations of Trp53 plasmids ( Figure 1c and data not shown). Together, the results indicate that Trp53 72P has a much higher potential to preferentially induce Trp53-dependent DNA-repair target gene promoters.
Generation of isogenic cell lines expressing Trp53
72R or Trp53
72P
In an attempt to investigate the physiological consequences of the differential activation of target gene promoters by Trp53
72P and Trp53
72R
, we generated isogenic cell lines expressing these two variants. Trp53 null H1299 (lung cancer) and UISO (melanoma) cells were transfected with temperature-sensitive Trp53 72R or Trp53 72P plasmids and stable cells were generated. Two temperature-sensitive mutations were independently made, which gave similar results: amino acid 143 (valine to alanine) or amino acid 138 (alanine to valine). The temperature-sensitive Trp53 variants are active at 321C and inactive at 391C (Michalovitz et al., 1990; Dumont et al., 2003) . Cells from the 138 temperature-sensitive panels expressing equal amounts of Trp53 both at the RNA and protein level were used in the subsequent experiments ( Figure 2a (Thomas et al., 1999) . In order to exclude any differential changes in conformation that may specifically affect the function of either polymorph, we performed immunoprecipitations with the conformation-specific 1620 antibody. This antibody specifically recognizes p53 in the wild-type conformation at 321C (Zhang et al., 1994) . Immunoprecipitation of lysates from cell lines indicated that the polymorphism did not alter the conformation, as both Trp53 72R and Trp53 72P were equally detected by the 1620 antibody at 321C (Figure 2c ). Similar data were obtained throughout with 143 temperature-sensitive cell lines (data not shown).
Using these cells, we evaluated the induction of Trp53 target genes such as p21 and Mdm2 subsequent to temperature shift. Expression of both p21 and Mdm2 were induced at 321C, as detected by semiquantitative RT-PCR and immunoblot analysis (Figure 2d-f . (a) Indicated amounts of pcDNA-empty vector, Trp53 72R or Trp53 72P expression plasmids were co-transfected with the gadd45 promoter-luciferase reporter construct into Trp53 null human H1299 cells, together with 0.5 mg of plasmid encoding the beta-galactosidase gene which was used for normalizing transfection efficiency. Cells were collected at 24 h post-transfection. All experiments were performed in duplicates at least three times independently. Error bars and P-values are indicated. Western-blot analysis was performed using half the samples from the transfections to determine the expression status of Trp53 in all cases. (b) Similar experiments were performed using the p53R2 promoter-luciferase construct in SAOS2 cells (right panel) and Trp53 null MEFS (left panel). (c) Reporter assays were similarly performed with p21, p53AIP-1 and Mdm2 promoters. (Dumont et al., 2003) , and together confirms that the isogenic cell systems are functional.
Trp53 dependent DNA-repair target genes are differentially regulated in Trp53 72P -and Trp53
72R -expressing isogenic cell lines
We next evaluated if the Trp53-dependent DNA-repair target genes are differentially regulated in the isogenic cell systems. H1299 cells were shifted to permissive temperature and expression of gadd45, p53R2 and p48, another DNA-repair gene, was monitored at various time points. None of the targets genes were activated at 391C (Figure 3a) . However, although all these genes were activated by 2 h post-temperature shift, the expression was much higher in Trp53 72P -expressing cells (Figure 3a) . At 16 h post-temperature shift, the levels of p48 and p53R2 were still higher in Trp53 72P -expressing -expressing cells and cells cultured at 391C (Figure 3c ). By contrast, p21 expression was induced to similar extents in both Trp53 72P and Trp53 72R cells after UV irradiation and temperature shift (Figure 3c ). Together, these data supports our previous results and indicates that Trp53 72P is capable of activating endogenous Trp53-dependent DNA-repair target genes much more efficiently than Trp53 72R . . To this end, two assays were initially employed.
The host-cell reactivation assay is a method of investigating the DNA-repair capacity of cells by quantifying the function of repaired exogenous DNA that had been damaged before introduction into cells (Mallya and Sikpi, 1998; Yang et al., 1998; Cho et al., 2002; Wani et al, 2002 In order to further evaluate this effect, we analysed the roles of Trp53 72P and Trp53 72R using the in vivo endjoining assay. DNA end-joining is part of the mechanism for repairing double-strand DNA breaks (Critchlow and Jackson, 1998; Karran, 2000) , and p53 has been shown to promote this process (Yang et al., 1997; Tang et al., 1999; Lin et al., 2003) . The pGL3-luciferase reporter plasmid was used to evaluate correct nonhomologous end-joining (NHEJ) activity that precisely rejoins broken DNA ends in vivo. The pGL3 plasmid was completely linearized by restriction endonuclease NarI and transfected into the isogenic temperature sensitive cell lines. All cells expressing the undamaged plasmid exhibited luciferase activity at both 39 and 321C when analysed 18 h post-transfection (Figure 4c ). However, significantly more luciferase activity from damaged plasmid was detected only in Trp53 -expressing cells UV irradiation results in dipyrimidine photoproducts such as (6-4)-photoproducts and cyclobutane pyrimidine dimers (CPDs), the latter being predominant (Patrick, 1977) . NER has been shown to be involved in the removal of CPDs, and defects in this process often lead to predisposition to cancer (Hanawalt et al., 2003) . Southwestern dot-blot analysis using an antibody directed against CPDs is one method to investigate the rate of removal of CPDs from DNA (Schwarz et al., 2002) . As we observed that Trp53 72P -expressing cells were able to repair damaged DNA faster, we investigated if removal of CPDs would occur faster in Trp53 72P -expressing cells. All isogenic temperature-sensitive cell types were treated with UV irradiation and genomic DNA was collected at various time points, and equal amounts of genomic DNA was used to detect CPDs (Figure 6a , loading shown in lower panel). Untreated cells did not contain any CPDs both at 39 and 321C (Figure 6a ), suggesting that in vitro crosslinking of genomic DNA onto membranes have not significantly contributed to any CPD dimer formation. UV treatment resulted in the formation of CPDs immediately (within 5 min). The amount of CPDs detected in vector-expressing cells gradually decreased over time, and 38% of CPDs were still detected at the 4 h post-irradiation (Figure 6a and b) . By contrast, CPDs were removed much more rapidly in both Trp53 72P -and Trp53
72R
-expressing cells, indicating that the presence of Trp53 enhances this DNA-repair process. However, most CPDs were removed significantly faster and as early as 1.5 h in Trp53 72P -expressing cells, whereas it took between 2-3 h for the removal of 
Formation of micronuclei is reduced in Trp53
72P -expressing cells Micronuclei (MN) are small nuclei known to represent extranuclear chromosomal fragments that are not incorporated into the nucleus during mitosis and arise from acentric chromatids or chromosome fragments induced by radiation or other DNA damages (Thoday, 1951) . Thus, MN formation is related to chromosomal aberration and has been used widely to measure chromosome damage, and is recognized as a consequence of genome instability (Matsuoka et al., 1992; Stopper et al., 1997; Fenech and Crott, 2002 72P expression. Cells were treated with IR and cultured for 24 h to allow repair of damaged DNA in the presence of cytochalasin B, which prevents cytokinesis at telophase, and the number of MN were enumerated from 500 binucleated cells in each experiment. All experiments were performed at least three independent times and representative results are shown. Untreated cells did not contain significant numbers of MN at 321C (Figure 7a , top row and 7b) and at 391C (data not shown). Irradiation of cells led to MN formation to equal extents at 391C in cells expressing either vector or the Trp53 variants, indicating that DNA damage has occurred and Trp53 was unable to correct the defects at this inactivating temperature. Vector-expressing cells grown at 321C also had many MN, similar to that found at 391C (Figure 7a and b) . Though presence of active Trp53 at 321C led to a decrease in the number of MN compared to vector-expressing cells after irradiation, the (Figure 7a showing representative pictures). These differences were consistently reproducible. Together, these data suggest that Trp53 72P -expressing cells are better able to cope with DNA damage by virtue of their ability to repair the damage better.
Discussion
The results presented here demonstrate that Trp53
72P is more efficient in its DNA-repair capacity than Trp53 72R . The increased repair efficiency can be correlated to efficient induction of Trp53-dependent DNA-repair target genes by Trp53
72P
, in contrast to other apoptotic and cell-cycle arrest target genes. These data thus highlight yet another important functional difference between these two forms of Trp53, and suggests that their expression status may thus influence cancer risk or treatment.
It should be emphasized that although Trp53 72P is more efficient in its repair capacity than Trp53 72R , the latter is not completely defective, but is just less efficient in its ability to repair damaged DNA. In addition, Trp53 72R -expressing cells are less able to remove MN, which is related to chromosomal aberration and has been used widely to measure chromosome damage, suggesting that Trp53 72R might be less potent in reducing genomic instability, and perhaps cancer predisposition. Consistent with this notion, our recent data indicated that whereas healthy Trp53 72R /Trp53 72P heterozygote individuals tend to preferentially express the Trp53 72P allele at the RNA level, the Trp53 72R allele was preferentially expressed in most heterozygote breast cancer patients, suggesting that Trp53 72R expression correlates with breast cancer development . Moreover, it was also demonstrated that there is a significant positive association between Trp53 72R and susceptibility to sunburn, which is a known risk factor, leading to a significant association between Trp53 72R homozygosity and non-melanoma skin cancer in renal transplant recipients (McGregor et al., 2002) . These data together indicate that Trp53 72R might be a predisposing allele to cancer, probably owing to its reduced ability to repair damaged DNA, a process that has been shown to be important in cancer formation.
In addition, it is noteworthy that mutations in the Trp53 gene are less frequently found in Trp53
72R patients compared to Trp53 72P patients. Mutations in the Trp53 gene were found in about 30% of Asian and 28% of Caucasian breast cancer patients expressing the Trp53 72R allele (Langerod et al., 2002; Siddique et al., 2005) . By contrast, about 55% Trp53 72P expressers were found to have a mutation in the Trp53 gene, which suggests that the Trp53 72R allele might perhaps be a weaker allele that does not require a mutation for cancer to develop.
It is intriguing to note that Trp53 72R is only slightly less efficient than Trp53 72P in its ability to repair damaged DNA. Nonetheless, the differences were observed consistently and were reproducible in many independent experiments, and hence, significant, and probably not owing to the temperature-sensitive cellular system used in the study. We have used two independent cell lines and two different temperature-sensitive mutations, all of which gave consistent results. Moreover, the conformation of both the polymorphs were efficiently changed at 321C, excluding the possibility that differential conformation change may be contributing to the different transactivation properties of the polymorphs. Furthermore, both polymorphs were found to transactivate p21 and Mdm2 genes equally, thereby further excluding any bias of the cellular system. Therefore, the question that arises is whether such small differences in the DNA-repair capacity is sufficient enough for Trp53
72R
-expressing people to become more susceptible to cancer development than Trp53 72P -expressers. However, it should also be noted that functional changes owing to polymorphisms might not be of a higher magnitude in reality, giving rise to 'all-or-none' effects. Subtle differences manifested owing to combination of polymorphic effects in several gene loci may result in the overall sensitivity to cancer development. In this respect, it was recently shown that the polymorphism in the Mdm2 promoter (SNP309) was involved in cancer susceptibility (Bond et al., 2004) . Although the weaker Mdm2 allele was expressed at low levels, its expression was not completely abolished (Bond et al. 2004) . Therefore, it can be envisaged that small but significant differences owing to polymorphic variations can be contributory to phenotypic manifestations of a disease.
The data shown here indicate that Trp53 72P is a better activator of Trp53-dependent DNA-repair target genes compared to Trp53
. This property of Trp53 72P was specific to DNA-repair target genes as apoptosis and cell-cycle related genes were regulated to similar extents by Trp53 72P and Trp53
. These findings are supported by the original observation by Thomas et al. (1999) , who have suggested that Trp53 72P and Trp53 72R have differential abilities to transactivate Trp53 target genes, using the synthetic Trp53CON promoter elements. However, it is important to note that Trp53 72R was not defective in transactivating these DNA-repair target genes, but it is just not as efficient as Trp53
72P
. This could also explain why many investigators have not noticed the small differences earlier. Nevertheless, the mechanisms for this differential ability to transactivate target genes is not clear at present, although differences in the ability of Trp53 72R or Trp53 72P to bind to DNA was not observed (Thomas et al., 1999 and data not shown). It is possible that Trp53
72P may bind better with transcription cofactors on the Trp53-dependent DNA-repair promoters, thereby enhancing the transactivation potential. Support for this comes from the earlier studies which suggested that Trp53
72P is able to bind basal (Thomas et al., 1999) . Whether there are specific co-factors that preferentially bind to Trp53 72P on Trp53-dependent DNA-repair target promoters remains to be investigated.
Trp53-mediated activation of gadd45 and p48 has been shown to regulate NER, and activation of p53R2 has been shown to be essential for providing nucleotides during the repair process (Kastan et al., 1992; Hwang et al., 1999; Smith et al., 2000; Tanaka et al., 2000) . These target genes were much more efficiently induced by Trp53
72P than Trp53
72R
, thereby supporting a role for the increased transcriptional activity of Trp53 72P in enhancing its DNA-repair capacity. Besides the transactivation-dependent function, transactivation-independent functions of Trp53 have also been implicated in DNA-repair (Sengupta and Harris, 2005) , and hence, we cannot exclude the possibility that there may be other transactivation-independent functions of Trp53
72P that contribute to its enhanced DNA-repair capacity. Furthermore, it is to be noted that Trp53 was shown to both augment and inhibit NHEJ (Yang et al., 1997; Tang et al., 1999; Akyuz et al., 2002; Okorokov et al., 2002; Lin et al., 2003; Dahm-Daphi et al., 2005) . These conflicting data could be attributed to the different methodologies used by the various investigators to study NHEJ. Nevertheless, our data, derived from several independent DNA-repair assays, support a positive role for Trp53 72P in repairing damaged DNA, which could be both dependent and independent of its transactivation potential.
The data presented here, together with the other reports indicating a preferential role of the Trp53 72R allele in apoptosis induction, indicate that the different polymorphs of Trp53 may have been selected for specific functions. However, it is important to note that both the polymorphs are endowed with both apoptosis and DNA-repair properties, but with different efficiencies. Thus, the polymorphism at codon 72 may serve as a genetic modifier, thereby allowing fine-tuning of these biological processes, perhaps as a consequence of ecological adaptation. Supporting this notion, populations expressing Trp53
72R were found to respond to stress signals such as sunlight by preferentially inducing cell death, as exemplified by their higher susceptibility to sunburn (McGregor et al., 2002) . Thus, apoptosis may be the preferential first line of defense against genotoxic stress in Trp53 72R populations. This idea is further supported by clinical data which shows that Trp53 72R patients without Trp53 mutations respond much better to chemotherapy, and survive longer compared to Trp53 72P patients (Sullivan et al. 2004) . By contrast, the role of Trp53 72P with respect to response to DNA damaging agents (in contrast to cytotoxic agents) is lacking and should provide useful insights into the clinical relevance of the current findings.
In summary, the data presented here demonstrate that the Trp53 72P polymorph of Trp53 has a selective advantage over Trp53 72R with respect to its ability to repair damaged DNA, at least in part owing to its ability to transactivate Trp53-dependent DNA-repair target genes better. These data suggest that the status of the codon 72 polymorphism may influence cancer susceptibility, but this effect may be dependent on the property of the cancer-inducing agent. Therefore, it is imperative to re-evaluate the role of codon 72 polymorphism in cancer predisposition, especially with respect to the various pathways activated by carcinogenic agents.
Materials and methods
DNA constructs, generation of isogenic cell lines and cell survival assays Human Trp53 cDNA was cloned in pCDNA3 (Invitrogen) eukaryotic expression vector that was used as a template for site-directed mutagenesis (SDM). Primers for the polymorphic site and one for introducing the temperature-sensitive site at amino-acid 143 (valine to alanine) or amino-acid 138 (alanine to valine) (Friedlander et al., 1996; Dumont et al., 2003) , were used for SDM, as per manufacturer's instructions (Startagene). Plasmids were sequenced to confirm the presence of the polymorphic site and the temperature-sensitive mutation (data not shown).
Trp53 null H1299 lung cancer cell line (ATCC), Saos-2 osteosarcoma cell line (ATCC), the melanoma cell line UISOMel6 (UISO) (gift from Dr Das Gupta) (Rauth et al., 1994) , as well as the Trp53 null mouse MEFs were used in this study. All cell lines were cultured in Dullbeco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (Hyclone) in presence of 5% CO 2 at 371C, as described by Vikhanskaya et al. (2005) .
H1299 and UISO cells were transfected with 2 mg of the temperature-sensitive Trp53 expression constructs and selected in the presence of Geneticin (800 mg/ml) (Gibco) to obtain stable cell lines. The Trp53 is functionally inactive and in mutant conformation at 391C but adopts a wild-type conformation and is active at 321C.
Cell survival was assessed by propidium iodide (PI) exclusion and Annexin-V (Pharmingen) staining, as described . All experiments were performed in triplicates, and at least three independent times. The standard deviations are indicated in the graphs.
Luciferase assays
Transient transfections were performed with 10, 100, 200 or 500 ng of Trp53 plasmids as indicated and 0.5 mg each of the indicated luciferase reporter plasmid, and the plasmid encoding the beta-galactosidase gene for evaluating the transfection efficiency. The following pGL3 basic vector-based (Promega) Trp53-responsive promoter reporter constructs were used in this study: p53R2-luc (gift of Dr H Arakawa), gadd45-luc, p21-luc, mdm2-luc and p53AIP-1-luc. Cells were generally collected 48 h post-transfection or at indicated time points. Luciferase assays were performed in triplicates, as described (Toh et al., 2005) . All reporter assays were performed at least three times independently, and representative results are shown. Half of the samples were used for immunoblotting to evaluate the expression status of the transfected plasmids.
Western-blot analysis
Cell lysates were prepared as described . Immunoprecipitations were carried out using anti-p53 1620 antibody (Oncogene Sciences) that specifically recognizes p53 in the wild-type conformation (Zhang et al., 1994) . Immunoprecipitates were resolved by electrophoresis on a 10% acrylamide gel and immunoblotted with anti-p53 antibody (Clone DO-1) (Santa Cruz). Proteins were also analysed by immunoblotting using anti-Trp53 (clone DO-1) (Santa Cruz), anti-p21 (clone C-19, Santa Cruz), anti-Trp53R2 (Sigma), antiEgfp (Clonetech) and anti-Actin (Sigma) antibodies, as described .
RNA and semiquantitative RT-PCR Total RNA was extracted from cultured cell lines using Trizol reagent (Invitrogen), as per manufacturer's instructions. Total RNA was reverse transcribed to first strand cDNA, which was used as a template for quantitative PCR, subsequent to optimization of the number of PCR cycles, annealing temperature and extension time, for each gene. Host reactivation assay pGL3 luciferase plasmid was damaged by UVB (250 J/m 2 ) or gamma irradiation (25 Gy) and 500 ng of the damaged plasmid was co-transfected with wild-type Trp53 (10 ng) plasmid into p53 null mouse MEFs. The cell lines were cultured for indicated time periods to allow repair of damaged DNA and the luciferase activity was determined thereafter. High luciferase activity corresponds to efficient DNA-repair and vice versa.
In vivo DNA-repair assay pGL3 basic vector digested with restriction enzyme Nar I which cuts at a unique site in the luciferase gene. 500 ng of the digested plasmid was co-transfected with 500 ng of b-galactosidase plasmid into the temperature-sensitive Trp53 containing H1299 stable cell lines, and luciferase activity was determined at 18 and 48 h after transfection.
Unscheduled DNA synthesis Twenty millimolar of hydroxyurea was added to 1 Â 10 4 cells in each well of a flat-bottomed 96-well plate to stop cells from dividing. Cells were cultured at 321C for 1 h to activate Trp53 before UV treatment (25 and 50 J/m 2 ) to induce DNA damage. Cultures were allowed to repair damaged DNA in the presence of 15 mci/ml of 3 H and 20 mM of hydroxyurea. Cells were then transferred to glass fibre filter (Wallac, Finland) using cell harvester (TOMTEC) and incorporation of 3 H during UDS was measured using scintillation counter (1450 Microbeta Counter, Trilux, Wallac).
South-Western analysis
Cells were treated with UV (50 J/m 2 ) and genomic DNA was extracted at indicated time points using the Promega SV Genomic DNA extraction kit, as per manufacturer's instructions. 500 ng of genomic DNA were diluted to 10 ml with 2 Â SSC (final concentration) and blotted on a nylon membrane followed by UV cross-linking (DNA containing side facing downwards) to fix DNA onto the membrane. The blot was blocked for 1 h at room temperature and incubated with anti-thymidine mouse monoclonal antibody (against CPDs) (Kamiya, USA) and detected with anti-mouse IgG horseradish peroxidase-labelled secondary antibody, similar to Western-blotting procedures. Identical amounts of genomic DNA were run on an agarose gel for evaluating the loading control.
Micronuclei analysis
Cells were treated with gamma irradiation (30 Gy) and cultured for 24 h to allow repair of damaged DNA in the presence of cytochalasin B (5 mg/ml), which prevents cytokinesis at telophase. Cells were trypsinized and fixed with cold methanol:acetic acid (3:1). A volume of 50 ml acridine orange solution (0.03 mg/ml in 1 Â PBS) was added to the slide, which was visualized under fluorescence microscope using DAPI/ FITC/TRITC filter.
Statistical analysis
Student's t-test was used to test for statistical significance of the differences between the different group parameters in the arg and pro expressing cells in all cases, except Figure 7 , and only those with Po0.05 were considered significant. For Figure 7 , w 2 -test was performed.
